Karsten Schlemm MD, CEO of Merz Pharma Austria, a leading international German based aesthetic company, provides an in-depth look into the company´s transformation from pharmaceuticals to the aesthetics sector as well as their exciting new offerings for cosmetic patients. He also gives an insight into the growing weight and Austrians’ mentality towards aesthetics and how Merz´s partner style relationship with physicians and consumers will allow it to become a world leader in aesthetics long term.
Merz at a global level has transformed its image in recent years moving heavily into aesthetic medicine. How has this trickled down to the Austrian level?
"This focus on medical aesthetics as a global strategy has been hugely successful."
